How much does Bioscientifica Limited make?

Bioscientifica Limited reported revenue of £3.1m and £837k profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

Is Bioscientifica Limited profitable?

Yes — Bioscientifica Limited reported a profit of £837k in the year to 31 Dec 2025.

Company No. 03190519 · Incorporated 25 Apr 1996

Bioscientifica Limited

Registered name: BIOSCIENTIFICA LIMITED

Bioscientifica Limited made £3.1m revenue and £837k profit in the year to 31 Dec 2025.

Bioscientifica Limited’s revenue fell 16% to £3.1m in the year to 31 Dec 2025, with £837k profit. The company is classified under “publishing of learned journals” and is based in Stoke Gifford; we hold 3 years of its filed accounts.

Full P&L filedSection J · Information and communicationSIC 58141Publishing of learned journals SIC 85590Other education n.e.c.SIC 86900Other human health activities SIC 94990Activities of other membership organizations n.e.c.

Status: Active
Location: Stoke Gifford, South West
Age: 30 yrs · since 1996
Type: Private Limited Company

Latest accounts · year to 31 Dec 2025

Key figures

Independent

Revenue

£3.1m

Growth ▼16.3%

Profit

£837k

Growth ▲97.9%

Profit margin

26.8%

Gross 39.6%

Employees

—

Change —

Profit / employee

—

Profitable streak

3yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

3 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£4.2m	£3.7m	£3.1m
Cost of sales	−£2.5m	−£2.4m	−£1.9m
Gross profit	£1.6m	£1.3m	£1.2m
Operating profit	£560k	£332k	£752k
Profit before tax	£595k	£423k	£837k
Profit after tax	£595k	£423k	£837k
Profit (best available)	£595k	£423k	£837k
Employees (average)	—	—	—
Ratios
Profit margin	14.3%	11.3%	26.8%
Gross margin	39.4%	35.1%	39.6%
Growth (year on year)
Revenue growth	—	▼10.4%	▼16.3%
Profit growth	—	▼28.9%	▲97.9%
Balance sheet — indirect signals, not revenue
Net assets	—	—	—
Source	Accounts · bulk data May 2025	Accounts · bulk data May 2025	Accounts · bulk data May 2026

Derived from the latest filing

How the business works

Profit margin: 26.8%; Profit ÷ revenue.
Gross margin: 39.6%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now —
Cash at bank: —; Now —
Headcount: —; Now —
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Minority corporate shareholders

Society for Endocrinology

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from accounts for the year to 31 Dec 2025 (profit £837k), from the Companies House accounts bulk data published May 2026. Spotted an error? Request a correction.

Updated from Companies House on 12 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.